UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Sex, Race, and Smoking Impact Olanzapine Exposure

Journal of clinical pharmacology, 2008-02, Vol.48 (2), p.157-165

2008

Volltextzugriff (PDF)

Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study

British journal of clinical pharmacology, 2008-11, Vol.66 (5), p.629-639

2008

Volltextzugriff (PDF)

Determination of ziprasidone in human plasma by liquid chromatography–electrospray tandem mass spectrometry and its application to plasma level determination in schizophrenia patients

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007-03, Vol.847 (2), p.237-244

2007

Volltextzugriff (PDF)

Pharmacokinetics and tissue distribution of olanzapine in rats

Biopharmaceutics & drug disposition, 1999-11, Vol.20 (8), p.369-377

1999

Volltextzugriff (PDF)

Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats

Psychopharmacologia, 2002-02, Vol.159 (4), p.424-431

2002

Volltextzugriff (PDF)

Simultaneous determination of risperidone and 9-hydroxyrisperidone in plasma by liquid chromatography/electrospray tandem mass spectrometry

Journal of mass spectrometry., 2000-06, Vol.35 (6), p.718-724

2000

Volltextzugriff (PDF)

Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia

The American journal of psychiatry, 2001-11, Vol.158 (11), p.1835-1842

2001

Volltextzugriff (PDF)

Ovariectomy results in lower plasma haloperidol levels in rats following chronic administration

Pharmaceutical research, 1998-10, Vol.15 (10), p.1640-1642

1998

Volltextzugriff (PDF)

Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat

Psychopharmacologia, 1998-10, Vol.139 (4), p.356-363

1998

Volltextzugriff (PDF)

Adverse extrapyramidal effects in four horse given fluphenazine decanoate

Journal of the American Veterinary Medical Association, 2006-07, Vol.229 (1), p.104

2006

Volltextzugriff (PDF)

Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements : A prospective dose-adjusted drug interaction strategy

Journal of clinical psychopharmacology, 2005-04, Vol.25 (2), p.170-174

2005

Volltextzugriff (PDF)

Plasma Levels of Fluphenazine in Patients Receiving Fluphenazine Decanoate Relationship to Clinical Response

British journal of psychiatry, 1991-05, Vol.158 (5), p.658-665

1991

Volltextzugriff (PDF)

Intra- and interindividual variations in steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients treated chronically with various doses of risperidone

Therapeutic drug monitoring, 2003-12, Vol.25 (6), p.657-664

2003

Volltextzugriff (PDF)

Plasma level monitoring of olanzapine in patients with schizophrenia : Determination by high-performance liquid chromatography with electrochemical detection

Therapeutic drug monitoring, 1997-06, Vol.19 (3), p.307-313

1997

Volltextzugriff (PDF)

Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores

Magnetic resonance in medicine, 1993-04, Vol.29 (4), p.459-464

1993

Volltextzugriff (PDF)

Does N-Desmethylolanzapine Increase, or Reduce, the Risk for Antipsychotic-Induced Metabolic Syndrome?

Journal of clinical psychopharmacology, 2005-12, Vol.25 (6), p.627-628

2005

Volltextzugriff (PDF)

Determination of Risperidone in Plasma by High-Performance Liquid Chromatography with Electrochemical Detection: Application to Therapeutic Drug Monitoring in Schizophrenic Patients

Journal of pharmaceutical sciences, 1993-05, Vol.82 (5), p.447-449

1993

Volltextzugriff (PDF)

Distribution of Fluphenazine and Its Metabolites in Brain Regions and Other Tissues of the Rat

Neuropsychopharmacology (New York, N.Y.), 1995-11, Vol.13 (3), p.235-247

1995

Volltextzugriff (PDF)

Fluphenazine levels during maintenance treatment of recent-onset schizophrenia : relation to side effects, psychosocial function and depression

Psychopharmacologia, 2000-03, Vol.148 (4), p.350-354

2000

Volltextzugriff (PDF)

Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2 but not dopamine D-1 receptors

Life sciences (1973), 1989, Vol.44 (3), p.229-236

1989

Volltextzugriff (PDF)

RADIOIMMUNOASSAYS FOR THE SULFOXIDE, 7-HYDROXY AND N(4')-OXIDE METABOLITES OF TRIFLUOPERAZINE: DEVELOPMENT AND APPLICATIONS

ARAVAGIRI, MANICKAM

1986

Volltextzugriff (PDF)

Regional differences in chronic neuroleptic effects on extracellular dopamine activity

Brain research bulletin, 1992-09, Vol.29 (3), p.473-478

1992

Volltextzugriff (PDF)

Chronic neuroleptic treatment in rats produces persisting changes in GABA A and dopamine D-2, but not dopamine D-1 receptors

Life sciences (1973), 1989, Vol.44 (3), p.229-236

1989

Volltextzugriff (PDF)

Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine

Therapeutic drug monitoring, 1994-02, Vol.16 (1), p.21-29

1994

Volltextzugriff (PDF)

Radioimmunoassay for the 7-Hydroxy Metabolite of Trifluoperazine and its Application to a Kinetic Study in Human Volunteers

Journal of pharmaceutical sciences, 1985-11, Vol.74 (11), p.1196-1202

1985

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)
Dissertationen
(1)

Sprache

Englisch
(28)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(25)
Biological And Medical Sciences
(21)
Medical Sciences
(20)
Pharmacology. Drug Treatments
(19)
Humans
(17)
Pharmacology & Pharmacy
(17)
Male
(13)
Animals
(11)
Female
(10)
Neuropharmacology
(10)
Adult
(9)
Antipsychotic Agents - Pharmacokinetics
(9)
Psycholeptics: Tranquillizer, Neuroleptic
(9)
Psychology. Psychoanalysis. Psychiatry
(9)
Psychopharmacology
(9)
Schizophrenia - Drug Therapy
(9)
Psychiatry
(8)
Rats
(8)
Analysis
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sex, Race, and Smoking Impact Olanzapine Exposure

Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study

Determination of ziprasidone in human plasma by liquid chromatography–electrospray tandem mass spectrometry and its application to plasma level determination in schizophrenia patients

Pharmacokinetics and tissue distribution of olanzapine in rats

Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats

Simultaneous determination of risperidone and 9-hydroxyrisperidone in plasma by liquid chromatography/electrospray tandem mass spectrometry

Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia

Ovariectomy results in lower plasma haloperidol levels in rats following chronic administration

Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat

Adverse extrapyramidal effects in four horse given fluphenazine decanoate

Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements : A prospective dose-adjusted drug interaction strategy

Plasma Levels of Fluphenazine in Patients Receiving Fluphenazine Decanoate Relationship to Clinical Response

Intra- and interindividual variations in steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients treated chronically with various doses of risperidone

Plasma level monitoring of olanzapine in patients with schizophrenia : Determination by high-performance liquid chromatography with electrochemical detection

Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores

Does N-Desmethylolanzapine Increase, or Reduce, the Risk for Antipsychotic-Induced Metabolic Syndrome?

Determination of Risperidone in Plasma by High-Performance Liquid Chromatography with Electrochemical Detection: Application to Therapeutic Drug Monitoring in Schizophrenic Patients

Distribution of Fluphenazine and Its Metabolites in Brain Regions and Other Tissues of the Rat

Fluphenazine levels during maintenance treatment of recent-onset schizophrenia : relation to side effects, psychosocial function and depression

Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2 but not dopamine D-1 receptors

RADIOIMMUNOASSAYS FOR THE SULFOXIDE, 7-HYDROXY AND N(4')-OXIDE METABOLITES OF TRIFLUOPERAZINE: DEVELOPMENT AND APPLICATIONS

Regional differences in chronic neuroleptic effects on extracellular dopamine activity

Chronic neuroleptic treatment in rats produces persisting changes in GABA A and dopamine D-2, but not dopamine D-1 receptors

Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine

Radioimmunoassay for the 7-Hydroxy Metabolite of Trifluoperazine and its Application to a Kinetic Study in Human Volunteers

Suchergebnisse filtern